To investigate how populations of CD4+ effector and Treg cells change during immune response in cancer and how these two T cell subsets contribute to the T cell population in the tumor-draining lymph nodes and tumor tissue, we have followed immune response to transplantable B16 melanoma. The gene discussed is CD4; the disease is neoplasm.